2C-C: Difference between revisions
From Pharmacopedia
More actions
| [unchecked revision] | [pending revision] |
MDElliottMD (talk | contribs) Expand stub to full MedTemplate parameter set |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 8: | Line 8: | ||
| starting_dose = | | starting_dose = | ||
| preparations = | | preparations = | ||
| fda_max = | |||
| routes = | | routes = | ||
| onset = | | onset = | ||
| Line 20: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid, limited data)"> | |||
Erowid's dosage documentation for oral 2C-C<ref name="erowid-2cc-dose"> | |||
Erowid. 2C-C Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/2cc/2cc_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers; Erowid notes | |||
explicitly that "very few reports of 2C-C usage" exist and dosages | |||
"are not well known": | |||
* '''Light:''' 15-25 mg | |||
* '''Common:''' 25-35 mg | |||
* '''Strong:''' 35-55 mg | |||
Threshold and heavy tiers are not characterized. Duration approximately | |||
3 to 5 hours. Erowid's limited-data caveat should be reflected in any | |||
presentation of these figures. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | |||
| interactions = | |||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 31: | Line 48: | ||
}} | }} | ||
[[Category:Research chemicals]] | |||
[[Category:Phenethylamines]] | |||
[[Category:2C-x series]] | |||
[[Category:Classical Psychedelics (Serotonergic)]] | |||
[[Category:Psychedelics]] | |||